Alzheimer's Research

DEA Boosts Production Of Cannabis & Psychedelics For Research In 2023 The DEA is proposing that 6.7 million grams (14,770 pounds) of marijuana be grown for research, more than double the amount suggested for 2022 (3.2 million grams).  The agency also raised the quota for “all...

Wall Street analysts have shown a bullish sentiment towards pharmaceutical and healthcare companies that focus on the treatment of Alzheimer's disease. A few days ago, BMO Capital Market's hosted a conference call with Dr. Dennis Selkoe, a leading Alzheimer's diseases researcher....